| FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ... Cancers 12 (12), 3835, 2020 | 90 | 2020 |
| Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases AK Meißner, R Gutsche, N Galldiks, M Kocher, ST Jünger, ML Eich, ... Neuro-oncology 24 (8), 1331-1340, 2022 | 24 | 2022 |
| Use of advanced neuroimaging and artificial intelligence in meningiomas N Galldiks, F Angenstein, JM Werner, EK Bauer, R Gutsche, GR Fink, ... Brain pathology 32 (2), e13015, 2022 | 20 | 2022 |
| Evaluation of FET PET radiomics feature repeatability in glioma patients R Gutsche, J Scheins, M Kocher, K Bousabarah, GR Fink, NJ Shah, ... Cancers 13 (4), 647, 2021 | 20 | 2021 |
| Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases R Gutsche, P Lohmann, M Hoevels, D Ruess, N Galldiks, ... Radiotherapy and Oncology 166, 37-43, 2022 | 16 | 2022 |
| Automated brain tumor detection and segmentation for treatment response assessment using amino acid PET R Gutsche, C Lowis, K Ziemons, M Kocher, G Ceccon, CR Brambilla, ... Journal of Nuclear Medicine 64 (10), 1594-1602, 2023 | 14 | 2023 |
| Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression M Müller, O Winz, R Gutsche, RTH Leijenaar, M Kocher, C Lerche, ... Journal of Neuro-oncology 159 (3), 519-529, 2022 | 14 | 2022 |
| FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation. Cancers (Basel). 2020; 12 P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ... DOI: https://doi. org/10.3390/cancers12123835, 0 | 13 | |
| Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer AK Meißner, R Gutsche, N Galldiks, M Kocher, ST Jünger, ML Eich, ... Journal of neuro-oncology 163 (3), 597-605, 2023 | 8 | 2023 |
| Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant … R Gutsche, G Gülmüs, FM Mottaghy, F Gärtner, M Essler, D von Mallek, ... Frontiers in Nuclear Medicine 3, 1234853, 2023 | 3 | 2023 |
| Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients. Cancers 2021, 13, 647 R Gutsche, J Scheins, M Kocher, K Bousabarah, GR Fink, NJ Shah, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 3 | 2021 |
| Deep learning-based amino acid PET brain tumor segmentation for automated response assessment in patients with brain tumors R Gutsche, C Lowis, K Ziemons, M Kocher, G Ceccon, CR Brambilla, ... Nuklearmedizin-NuclearMedicine 63 (02), L53, 2024 | | 2024 |
| Example of Artificial Intelligence–Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management P Lohmann, R Gutsche, JM Werner, NJ Shah, KJ Langen, N Galldiks Journal of Nuclear Medicine, 2024 | | 2024 |
| NIMG-83. MULTIMODAL PET/MRI RADIOMICS AND CLINICAL PARAMETERS FOR OVERALL SURVIVAL PREDICTION IN PATIENTS WITH IDH WILDTYPE GLIOBLASTOMA R Gutsche, E Bauer, M Kocher, JM Werner, G Fink, N Shah, KJ Langen, ... Neuro-Oncology 24 (Suppl 7), vii184, 2022 | | 2022 |
| P13. 03. A. RADIOMICS FOR THE NON-INVASIVE ASSESSMENT OF THE PDL-1 EXPRESSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES IINSF FLUORESCENCE-GUIDED Neuro-Oncology, 2022 | | 2022 |
| NIMG-04. PREDICTING THE BRAF MUTATIONAL STATUS IN PATIENTS WITH MELANOMA BRAIN METASTASES USING RADIOMICS-A BICENTRIC STUDY AK Meissner, R Gutsche, N Galldiks, M Kocher, ST Juenger, ML Eich, ... Neuro-Oncology 23 (Supplement_6), vi127-vi128, 2021 | | 2021 |
| RADIOMICS FOR THE NON-INVASIVE DETERMINATION OF THE BRAF MUTATIONAL STATUS IN PATIENTS WITH MELANOMA BRAIN METASTASES A Meissner, R Gutsche, N Galldiks, M Kocher, ST Juenger, C Wendl, ... NEURO-ONCOLOGY 23, 39-39, 2021 | | 2021 |
| Radiomics for the non-invasive diagnosis of the BRAF mutational status in patients with melanoma brain metastases AK Meissner, R Gutsche, N Galldiks, M Kocher, ST Junger, ML Eich, ... JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 19, 9-9, 2021 | | 2021 |
| Evaluation of FET PET radiomics feature repeatability in patients with brain tumors R Gutsche, J Scheins, M Kocher, NJ Shah, K Langen, N Galldiks, ... Nuklearmedizin-NuclearMedicine 60 (02), P39, 2021 | | 2021 |
Philipp LohmannForschungszentrum JülichAdresse e-mail validée de fz-juelich.de